ProMISe Trial for Sepsis: Usual Care 3, Goal-Directed Therapy 0*

Mar 20, 2015

∙ Paid

* (since 2014)

The ARISE (Australasia) and ProCESS (U.S.) trials, published in 2014, each demonstrated no advantage of protocolized care for sepsis over conscientious usual care. For those remaining unconvinced, the U.K.-based ProMISe trial is available in the New England Journal of Medicine.

ProMISe extends the growing global footprint of what some will…

Keep reading with a 7-day free trial

Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.